Vertaling van "dimethyl ftalaat " (Nederlands → Engels) :

TERMINOLOGIE

dimethyl ftalaat
dimethyl phtalate

bis(2-ethylhexyl)ftalaat
Dioctylphthalate

di(methylcyclohexyl)ftalaat | sextolftalaat
di-(methylcyclohexyl)phthalate | sextolphthalate

di-(2-ethylhexyl)ftalaat | diethylhexylftalaat | DIEF [Abbr.]
bis(2-ethylhexyl) phthalate | diethylhexyl phthalate | DEHP [Abbr.] | DIHP [Abbr.]

bepalen van 2-ethylideen-1,5-dimethyl-3,3-difenylpyrrolidine in urine
Urine EDDP level

2,2-dimethyl-3-(3-methylfenyl)propanol
Majantol

IN-CONTEXT TRANSLATIONS

Mededeling van de Commissie inzake de resultaten van de risicobeoordeling en de strategieën ter beperking van de risico's voor de stoffen: piperazine; cyclohexaan; methyleendifenyldiisocyanaat; but-2-yn-1,4-diol; methyloxiraan; aniline; 2-ethylhexylacrylaat; 1,4-dichloorbenzeen; 4'-tert-butyl-2',6'-dimethyl-3',5'-dinitroacetofenon; bis(2-ethylhexyl)ftalaat; fenol; 5-tert-butyl-2,4,6-trinitro-m-xyleen (PB C 34 van 7.2.2008, blz. 1).
Commission communication on the results of the risk evaluation and the risk reduction strategies for the substances: Piperazine; Cyclohexane; Methylenediphenyl diisocyanate; But-2yne-1,4-diol; Methyloxirane; Aniline; 2-Ethylhexylacrylate; 1,4-Dichlorobenzene; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; Di-(2-ethylhexyl)phthalate; Phenol; 5-tert-butyl-2,4,6-trinitro-m-xylene (OJ C 34, 7.2.2008, p. 1).

De resultaten van de risicobeoordeling en de verdere resultaten van de strategieën ter beperking van de risico’s worden vermeld in Mededeling van de Commissie van 7 februari 2008 inzake de resultaten van de risicobeoordeling en de strategieën ter beperking van de risico’s voor de stoffen: piperazine; cyclohexaan; methyleendifenyldiisocyanaat; but-2-yn-1,4-diol; methyloxiraan; aniline; 2-ethylhexylacrylaat; 1,4-dichloorbenzeen; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetofenon; bis(2-ethylhexyl)ftalaat; fenol; 5-tert-butyl-2,4,6-trinitro-m-xyleen (6).
The results of the risk evaluation and further results of the strategies for limiting the risks are set out in the corresponding Commission Communication of 7 February 2008 (6) on the risk evaluation and the risk reduction strategies for the substances: Piperazine; Cyclohexane; Methylenediphenyl diisocyanate; But-2yne-1,4-diol; Methyloxirane; Aniline; 2-Ethylhexylacrylate; 1,4-Dichlorobenzene; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; Di-(2-ethylhexyl)phthalate; Phenol; 5-tert-butyl-2,4,6-trinitro-m-xylene.